SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001203944-07-000040
Filing Date
2007-10-23
Accepted
2007-10-22 19:33:38
Documents
3
Period of Report
2007-10-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K RAPTOR OCTOBER 22 2007 form8k102207.htm 8-K 37434
2 RAPTOR PRESS RELEASE OCTOBER 22 2007 raptorpressrelease102207.htm EX-99 17936
3 GRAPHIC img1.jpg GRAPHIC 4451
  Complete submission text file 0001203944-07-000040.txt   63491
Mailing Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949 415-382-1390
RAPTOR PHARMACEUTICALS CORP. (Filer) CIK: 0001203944 (see all company filings)

IRS No.: 980379351 | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-50720 | Film No.: 071184250
SIC: 2834 Pharmaceutical Preparations